獸用疫苗市場規模、佔有率及成長分析（按類型、疾病、技術、給藥途徑、最終用戶和地區）－2025-2032 年產業預測

2023 年全球動物疫苗市場規模為 86 億美元，預計將從 2024 年的 92.1 億美元成長到 2032 年的 159.4 億美元，預測期內（2025-2032 年）的複合年成長率為 7.1%。

全球獸用疫苗市場正在經歷強勁成長，這得益於人們對動物健康的認知不斷提高以及對肉類、牛奶和蛋類等動物衍生產品的需求不斷成長。通用感染疾病的增加凸顯了預防措施的必要性，並進一步凸顯了糧食安全的關鍵作用。牲畜數量的增加以及對食品安全和永續性的日益重視正在推動市場擴張。疫苗有效性和安全性方面的創新正在獲得獸醫和寵物飼主的支持。此外，產業巨頭對研發的大量投資，加上開發中國家政府針對預防和根除動物疾病的舉措，正在推動市場成長。動物疾病發生率的上升和畜牧業（尤其是家禽）的擴張是市場動態的主要影響因素。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 專利分析
• 技術分析
• 案例研究
• 客戶和購買標準分析

動物疫苗市場規模（按類型及複合年成長率） (2025-2032)

• 市場概覽
• 牲畜疫苗
  • 牛疫苗
  • 小反芻動物疫苗
• 豬疫苗
• 家禽疫苗
• 寵物疫苗
  • 狗狗疫苗
  • 貓疫苗
• 水產養殖疫苗
• 其他動物疫苗

動物疫苗市場規模（依疾病區分）及複合年成長率（2025-2032）

• 市場概覽
• 牲畜疾病
  • 牛病
  • 小反芻動物疾病
• 豬病
• 家禽疾病
• 寵物疾病
  • 狗的疾病
  • 貓病
• 水產養殖疾病
• 其他獸醫疾病

動物疫苗市場規模（依技術及複合年成長率） (2025-2032)

• 市場概覽
• 減毒活疫苗
• 去活化疫苗
• 類毒素疫苗
• 重組疫苗
• 其他疫苗技術

動物疫苗市場規模（依給藥途徑和複合年成長率） (2025-2032)

• 市場概覽
• 皮下途徑
• 肌肉注射
• 口服途徑
• 鼻內/噴霧給藥途徑
• 眼內途徑
• 其他給藥途徑

動物疫苗市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 獸醫診所
• 獸醫診所
• 其他最終用戶

動物疫苗市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Zoetis, Inc.（US）
• Merck & Co, Inc.（US）
• Boehringer Ingelheim International GmbH（Germany）
• Elanco Animal Health（US）
• Virbac（France）
• Hester Biosciences Limited（India）
• Neogen Corporation（US）
• HIPRA（Spain）
• Biogenesis Bago（Argentina）
• Tianjin Ringpu Bio-Technology Co Ltd.（China）
• China Animal Husbandry Group（China）
• Jinyu Bio-technology（China）
• Vaxxinova International BV（Netherlands）
• Endovac Animal Health（US）
• Brilliant Bio Pharma（India）
• Aptimmune（US）
• Indian Immunologicals Ltd.（India）
• Torigen Pharmaceuticals, Inc.（US）
• VEROVACCiNES GmbH（Germany）
• Intas Pharmaceuticals（India）
• Ourofino Animal Health（Brazil）
• Biovac（Israel）
• Laboratoire LCV（France）

結論和建議

Global Veterinary Vaccines Market size was valued at USD 8.6 billion in 2023 and is poised to grow from USD 9.21 billion in 2024 to USD 15.94 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The global veterinary vaccines market is experiencing robust growth, fueled by heightened awareness of animal health and rising demand for animal-derived products like meat, milk, and eggs. The increasing incidence of zoonotic diseases has underscored the necessity of preventative measures, further highlighting the critical role of food security. A growing livestock population, alongside heightened emphasis on food safety and sustainability, drives market expansion. Innovations in vaccine efficacy and safety are gaining traction among veterinarians and pet owners. Additionally, significant investments from industry leaders in research and development, combined with government initiatives in developing countries targeting the prevention and eradication of animal diseases, are accelerating market growth. The rising prevalence of animal diseases and expanding livestock sectors, particularly poultry, contribute significantly to market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Vaccines Market Segments Analysis

Global Veterinary Vaccines Market is segmented by Type, Disease, Technology, Route Of Administration, End User and region. Based on Type, the market is segmented into Livestock Vaccines, Porcine Vaccines, Poultry Vaccines, Companion Animal Vaccines, Aquaculture Vaccines and Other Veterinary Vaccines. Based on Disease, the market is segmented into Livestock Diseases, Porcine Diseases, Poultry Diseases, Companion Animal Diseases, Aquaculture Diseases and Other Veterinary Diseases. Based on Technology, the market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Other Vaccine Technologies. Based on Route Of Administration, the market is segmented into Subcutaneous Route of Administration, Intramuscular Route of Administration, Oral Route of Administration, Intranasal/Spray Route of Administration, Intraocular Route of Administration and Other Routes of Administration. Based on End User, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Vaccines Market

The Global Veterinary Vaccines market is significantly driven by the rise in zoonotic diseases, which are illnesses that can be transmitted from animals to humans. The increasing prevalence of diseases such as rabies, avian influenza, and swine flu has led to a heightened demand for veterinary vaccines. By vaccinating domestic animals against these diseases, the risk of transmission to humans is mitigated, thereby enhancing public health and preventing potential outbreaks. Furthermore, global population growth and the shifting dietary preferences towards increased animal protein consumption, particularly in developing nations, have escalated the demand for livestock. This surge in interest and concern for animal health has resulted in a substantial expansion of the veterinary vaccines market.

Restraints in the Global Veterinary Vaccines Market

The global veterinary vaccines market faces significant constraints due to the intricate and prolonged process of developing and producing new vaccines, which involves extensive research, clinical trials, and regulatory approvals. The high costs associated with both the development and manufacturing of vaccines can render them unaffordable for many farmers and pet owners, particularly in resource-limited areas. Additionally, the expenses involved in ensuring proper storage and transportation under required conditions further increase the overall costs of vaccination. These financial barriers can hinder the widespread adoption of veterinary vaccines and inhibit market growth, especially in developing regions.

Market Trends of the Global Veterinary Vaccines Market

A significant trend in the Global Veterinary Vaccines market is the rising adoption of recombinant vaccines, leveraging advanced biotechnological methods for heightened efficacy and targeted protection against specific pathogens. These vaccines, designed as hybrids, not only enhance immunogenicity but also reduce the likelihood of adverse reactions, making them increasingly favored by veterinarians and pet owners alike. This shift aligns with a broader trend toward personalized medicine in veterinary care, as stakeholders seek innovative solutions that deliver improved health outcomes for animals. As awareness of these benefits grows, the demand for recombinant vaccines is expected to drive market expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Technology Analysis
• Case Studies
• Customer And Buying Criteria Analysis

Global Veterinary Vaccines Market Size by Type & CAGR (2025-2032)

• Market Overview
• Livestock Vaccines
  • Bovine Vaccines
  • Small Ruminant Vaccines
• Porcine Vaccines
• Poultry Vaccines
• Companion Animal Vaccines
  • Canine Vaccines
  • Feline Vaccines
• Aquaculture Vaccines
• Other Veterinary Vaccines

Global Veterinary Vaccines Market Size by Disease & CAGR (2025-2032)

• Market Overview
• Livestock Diseases
  • Bovine Diseases
  • Small Ruminant Diseases
• Porcine Diseases
• Poultry Diseases
• Companion Animal Diseases
  • Canine Diseases
  • Feline Diseases
• Aquaculture Diseases
• Other Veterinary Diseases

Global Veterinary Vaccines Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Other Vaccine Technologies

Global Veterinary Vaccines Market Size by Route Of Administration & CAGR (2025-2032)

• Market Overview
• Subcutaneous Route of Administration
• Intramuscular Route of Administration
• Oral Route of Administration
• Intranasal/Spray Route of Administration
• Intraocular Route of Administration
• Other Routes of Administration

Global Veterinary Vaccines Market Size by End User & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Other End Users

Global Veterinary Vaccines Market Size & CAGR (2025-2032)

• North America (Type, Disease, Technology, Route Of Administration, End User)
  • US
  • Canada
• Europe (Type, Disease, Technology, Route Of Administration, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Disease, Technology, Route Of Administration, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Disease, Technology, Route Of Administration, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Disease, Technology, Route Of Administration, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago (Argentina)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tianjin Ringpu Bio-Technology Co Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Animal Husbandry Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinyu Bio-technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxinova International BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endovac Animal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brilliant Bio Pharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aptimmune (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torigen Pharmaceuticals, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VEROVACCiNES GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ourofino Animal Health (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biovac (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoire LCV (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations